Skip to content

News Hub

The latest breaking stories

Access up-to-date news and information on a wide range of press releases including business, finance, technology, healthcare, entertainment, and more.

NewsMatch Alert

Discover the most important & comprehensive stories delivered directly to you daily.

  • Industrial Relations, Union
  • 01/04/2025
  • 06:46
Australian Services Union

Australian Services Union launches campaign to secure government support for a modernised SCHADS Award

The Australian Services Union (ASU) has today announced the launch of the Skilled, Respected, Equal Alliance – a coalition of sector organisations committed to securing better pay, career pathways, and government support for social, community, and disability sector workers. For three decades, workers in the social, community, and disability services sectors have been let down by an outdated classification system that fails to reflect the growing complexity of their roles. That’s why the ASU is uniting workers and employers to push for adequate funding and implementation of a fair, future-ready Social, Community, Home Care and Disability Services (SCHADS) Award. ASU…

  • Medical Health Aged Care
  • 01/04/2025
  • 06:15
Royal Australian College of GPs

GPs back Victorian infant RSV vaccine boost

The Royal Australian College of GPs (RACGP) has thrown its support behind Victoria’s infant RSV vaccine program. Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs. Following the Federal Government announcing a free maternal RSV vaccine for pregnant women to protect their baby under the National Immunisation Program (NIP), the Victorian Government has launched a complementary program offering neonatal and “catch up” vaccinations to protect infants and young children most at risk. The Victorian roll-out is designed for infants: born between 1 October last year to 30 September this year to mothers did…

  • General News, Medical Health Aged Care
  • 01/04/2025
  • 06:01
CSL Seqirus

Influenza cases already at highest to date with vaccines now available

CONSUMER MEDIA RELEASE To date, there have been over 46,300 lab-confirmed influenza cases in Australia, more than 50% higher than the previous record of flu cases in Australia during the first quarter (January – March 2024).1 The Northern Hemisphere has just experienced a significant influenza season with some UK hospitals overwhelmed by the winter peak and the US recording the largest influenza season since the 2009 Swine Flu Pandemic.2-4 Influenza vaccines have been released in preparation for Australia’s 2025 influenza flu season, including from CSL Seqirus’ Melbourne manufacturing facility. Melbourne, Australia 1 April – CSL Seqirus has announced that it…

  • Federal Election, Information Technology
  • 01/04/2025
  • 06:00
Monash University

Monash expert: Detecting deepfakes during election campaigns

A Monash University expert is available to comment on the generation ofdeepfakes during election campaigns, how to detect deepfakes and what cautionary measures can be taken against AI-generated misinformation. Associate Professor Abhinav Dhall, Department of Data Science & AI, Faculty of Information Technology Contact details: +61 450 501 248 or media@monash.edu Human-centred artificial intelligence Audio-visual deepfakes Computer vision The following can be attributed to Associate ProfessorDhall: “The use of generative AI makes it easier for legitimate election campaigning content to be generated but it also makes it easier and faster for miscreants to generate and spread misinformation or disinformation, as…

  • Medical Health Aged Care
  • 01/04/2025
  • 06:00
Alexion, AstraZeneca Rare Disease

First targeted treatment on the PBS for rare, unpredictable and debilitating autoimmune disease, NMOSD

Alexion, AstraZeneca Rare Disease treatment Ultomiris® (ravulizumab rch) has become the first targeted treatment option to be reimbursed for people living with Neuromyelitis Optica Spectrum Disorder (NMOSD) following its listing on the Pharmaceutical Benefits Scheme (PBS) from 1 April 2025.1-3 Ultomiris is now reimbursed for eligible Australians with anti-aquaporin 4 (AQP4) antibody-positive (Ab+) NMOSD who have experienced a recent relapse event, despite prior treatment with rituximab or who cannot tolerate rituximab.1-3 NMOSD is a rare disease in which the immune system is inappropriately activated to target healthy tissues and cells in the central nervous system, including the brain, spine and…

  • Contains:
  • Crime, General News
  • 01/04/2025
  • 05:00
RACV

RACV SHARES HOME SECURITY TIPS FOLLOWING 19 PER CENT RISE IN HOME BREAK-INS

RACV is urging Victorians to enhance their home security measures in response to an increase in residential burglaries across the state. The latest data…

  • Contains:
  • Mental Health, Youth
  • 01/04/2025
  • 04:30
Black Dog Institute

Mates, Mullets, and Mental Health – Australia, it’s time!

1st April: Black Dog Institute’s Mullets for Mental Health has officially kicked off, raising funds for groundbreaking mental health research Black Dog Institute is calling on Aussies everywhere to show they’re all ears by growing a mullet to support the 1 in 5 Australians who experience a mental illness each year. Back and bolder than ever, Mullets for Mental Health is the national fundraising challenge that brings together Australians of all hair types to shape and grow their mullets in the name of better mental health. For those rocking a mullet or thinking of embracing one, April 2025 is the…

  • Contains:
  • Business Finance
  • 01/04/2025
  • 04:11
Everen Group

Everen Group Promotes Karyn Peixoto to Chief HR Officer

HAMILTON, Bermuda–BUSINESS WIRE– The Everen Group is pleased to announce the promotion of Karyn Peixoto to the role of Senior Vice President, Chief Human…

  • Contains:
  • Medical Health Aged Care
  • 01/04/2025
  • 03:01
National Drug and Alcohol Research Centre (NDARC)

No evidence quit-smoking medicines increase risk of major birth defects, NDARC study finds

Pregnant women can be reassured that quit-smoking medicines such as nicotine patches and varenicline do not increase the risk of major birth defects in babies, according to new research from the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney. The real-world data, published in JAMA Internal Medicine, suggest there is no evidence that infants exposed to these medicines had higher rates of major congenital malformations. “Considering the devastating consequences of smoking on both mother and baby, our results should reassure pregnant women who need help quitting smoking,” said Dr Duong Tran, an NDARC Research Fellow and first author of…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.